DNMT3B and Miyoshi myopathy: This phenotype was reversed by the addition of piRNA 823 antagomir or DNMT3B inhibitor, demonstrating that IL-6 can also enhance the stemness in cancer cells, hence treatment resistance of MM by inducing epigenetic changes (Ai et al., 2019).